首页> 外文期刊>Collection of Czechoslovak Chemical Communications >Cytostatic 6-arylpurine nucleosides II. Synthesis of sugar-modified derivatives: 9-(2-deoxy-beta-D-erythro-pentofuranosyl)-, 9-(5-deoxy-beta-D-ribofuranosyl)- and 9-(2,3-dihydroxypropyl)-6-phenylpurines
【24h】

Cytostatic 6-arylpurine nucleosides II. Synthesis of sugar-modified derivatives: 9-(2-deoxy-beta-D-erythro-pentofuranosyl)-, 9-(5-deoxy-beta-D-ribofuranosyl)- and 9-(2,3-dihydroxypropyl)-6-phenylpurines

机译:抑制细胞生长的6-芳基嘌呤核苷II。糖修饰的衍生物的合成:9-(2-脱氧-β-D-赤型五呋喃糖基)-,9-(5-脱氧-β-D-核呋喃糖基)-和9-(2,3-二羟丙基)-6 -苯基嘌呤

获取原文
获取原文并翻译 | 示例
           

摘要

9-(2-Deoxy-beta -D-erythro-pentofuranosyl)-6-(4-substituted phenyl)purines, 9-(5-deoxy-beta -D-ribofuranosyl)-6-(4-substituted phenyl)purines and 9-(2,3-dihydroxypropyl)-6-(4-substituted phenyl)purines were prepared by the Suzuki-Miyaura cross-coupling reactions of the corresponding protected 9-substituted 6-chloropurines with substituted phenylboronic acids followed by MeONa mediated deprotection. In contrast to the highly active 6-phenylpurine ribonucleosides, the title compounds did not show any considerable cytostatic activity. [References: 23]
机译:9-(2-脱氧-β-D-赤-呋喃呋喃糖基)-6-(4-取代的苯基)嘌呤,9-(5-脱氧-β-D-核呋喃糖基)-6-(4-取代的苯基)嘌呤和通过相应的受保护的9-取代的6-氯嘌呤与取代的苯基硼酸的Suzuki-Miyaura交叉偶联反应,然后由MeONa介导的脱保护,制备9-(2,3-二羟丙基)-6-(4-取代的苯基)嘌呤。与高活性的6-苯基嘌呤核糖核苷相反,标题化合物没有显示任何明显的细胞抑制活性。 [参考:23]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号